idrx gsk news - Search News

GSK Plc, IDRx

Bloomberg on MSN · 1d

GSK Nears $1 Billion Deal for Biotech Company IDRx

GSK Plc is in talks to buy biotech company IDRx, people with knowledge of the matter said, a deal that would see the British drugmaker further boost its growing oncology portfolio.

pharmaphorum · 1d

Is GSK prepping a $1bn takeover bid for IDRx?

GSK is reportedly in late-stage negotiations about a $1 billion deal to acquire IDRx and its experimental targeted therapy for a form of rare gastrointestinal stromal tumour (GIST).

Seeking Alpha on MSN · 1d

GSK is said to be nearing $1B deal to acquire U.S. biotech IDRx

British pharma giant GSK (NYSE:GSK) is closing in on a $1B buyout deal to acquire IDRx, a U.S. biotech focused on developing drugs for rare gastrointestinal tumors, The Financial Times reported Wednesday.

Business Insider · 1d

GSK in advanced talks to purchase U.S. biotech IDRx, FT reports

GSK (GSK) is in advanced discussions to purchase privately-owned U.S. biotech IDRx, which is working on a treatment for rare gastrointestinal

Regeneron builds in eye disease tech with Oxular takeover

Regeneron has bought Oxular, a UK-based specialist in retinal diseases, in a move that bolsters its already strong position ...

3d

GSK’s GSK’227 receives FDA BTD for treating adults with relapsed osteosarcoma

GSK (GSK) announced that the US Food and Drug Administration, FDA, has granted Breakthrough Therapy Designation, BTD, for GSK5764227, GSK’227, ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results